SCHEMBL888469

SCHEMBL888469

ClCC1CCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28855716 1.00
SCHEMBL28455739 0.91
SCHEMBL991377 0.84
SCHEMBL3579589 0.82
SCHEMBL11671086 0.79
SCHEMBL5137142 0.78
SCHEMBL2768658 0.76
SCHEMBL6630034 0.74
SCHEMBL470130 0.72
SCHEMBL631210 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090284-A1 ELECTROLYTE COMPRISING SOLVENT WITH NON-FLUORINE HALOGEN SUBSTITUTE AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-05-01 WO claimed
CN-114686016-A Waste plastic regenerated high-weather-resistance plastic purse net and preparation method thereof 安徽鸿森塑业科技股份有限公司 2022-07-01 CN claimed
WO-2025090284-A1 ELECTROLYTE COMPRISING SOLVENT WITH NON-FLUORINE HALOGEN SUBSTITUTE AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-05-01 WO disclosed
EP-3884939-B1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS INC (US) 2023-10-25 EP disclosed
US-20230312536-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. 2023-10-05 US disclosed
US-20230312536-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. 2023-10-05 US disclosed
US-20230312536-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. 2023-10-05 US disclosed
US-11634412-B2 3-phosphoglycerate dehydrogenase inhibitors and uses thereof RAZE THERAPEUTICS, INC. (US) 2023-04-25 US disclosed
US-11634412-B2 3-phosphoglycerate dehydrogenase inhibitors and uses thereof RAZE THERAPEUTICS, INC. (US) 2023-04-25 US disclosed
US-20230009122-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. 2023-01-12 US disclosed
US-20230009122-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. 2023-01-12 US disclosed
US-20070281950-A1 NITROMETHYLENE DERIVATIVES AND THEIR USE EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2007-12-06 US disclosed
US-20070281950-A1 NITROMETHYLENE DERIVATIVES AND THEIR USE EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2007-12-06 US disclosed
EP-1826209-A1 NITROMETHYLENE DERIVATIVES AND THEIR USE East China University of Science and Technology (CN) 2007-08-29 EP disclosed
EP-1826209-A1 NITROMETHYLENE DERIVATIVES AND THEIR USE East China University of Science and Technology (CN) 2007-08-29 EP disclosed
CN-1295228-C Nitryl methylene derivatives and uses thereof UNIV EAST CHINA SCIENCE & TECH (CN) 2007-01-17 CN disclosed
CN-1631887-A Nitryl methylene derivatives and uses thereof UNIV EAST CHINA SCIENCE & TECH (CN) 2005-06-29 CN disclosed
CN-1572754-A Method for producing organic compound by substituting halogen atoms MITSUI CHEMICALS INC (JP) 2005-02-02 CN disclosed
US-20040256743-A1 Method for producing organic compound by substituting halogen atoms MITSUI CHEMICALS, INC. (JP) 2004-12-23 US disclosed
EP-1486479-A1 Method for producing organic compounds by substituting halogen atoms MITSUI CHEMICALS, INC. (JP) 2004-12-15 EP disclosed